Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ…
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Read the official notice →- Date
- 2023-07-19
- Country
- United States
- Brand
- Teva Pharmaceuticals
- Product
- Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC…
- Classification
- Class II
- Units
- Product was distributed to 3 wholesalers/distributors who further distributed…
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Teva Pharmaceuticals recalls
- 2024-02-21
US
Teva Pharmaceuticals USA, Inc recalls Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each…
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
- 2024-02-07
US
- 2023-12-06
US
- 2023-05-31
US
Teva Pharmaceuticals USA Inc recalls Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne…
Labeling: Incorrect or Missing Package Insert
- 2023-04-12
US
Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…
Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
- 2023-03-22
US
Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL…
Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Other drugs & medical recalls in the United States
- 2023-07-19
US
B. Braun Medical Inc. recalls 0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018-3524 USA, NDC…
Lack of assurance of sterility: bags have the potential to leak.
US
Tenn South Distillery LLC dba Big Machine Distillery recalls Big Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol Antiseptic 80% Topical Solution,…
CGMP Deviation: impurities exceed allowable limits.
US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512,…
Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing
US
L. Perrigo Company recalls allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC…
Failed Impurities/Degradation Specifications
US
Lupin Pharmaceuticals Inc. recalls Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
FDA · DrugLupin Pharmaceuticals Inc.Product was distributed directly to three distributors in TN and NJ. Product…Official notice →US
K.C. Pharmaceuticals, Inc recalls Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZ (15mL) bottle, packaged…
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.